Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

JUNS stock hub

Jupiter Neurosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JUNSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

JUNS

In the news

Latest news · JUNS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-738.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-141.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JUNS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001679628
Company name	Jupiter Neurosciences, Inc.
Country	United States
Country code	US
Employees	5
Employees Change	1%
Employees Change Percent	25
Enterprise value	$13.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-12-03
Isin	US48208B2034
Last refreshed	2026-05-10
Market cap	$12.1M
Market cap category	Nano-Cap
Price	$0.33
Price currency	USD
Rev Per Employee	4,359.2x
Sector	Healthcare
Sic	2834
Symbol	JUNS
Website	https://jupiterneurosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-71.6%
EV Sales Forward	1.1x
EV/Sales	624.17x
P/S ratio	553.97x
PS Forward	0.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-2.1M
Net Income	$-8.6M
Net Income Growth Years	0%
Pretax Margin	-39,662.77%
Profit Per Employee	$-1.7M
ROA	-94.64
Roa5y	-458
ROCE	486.3
ROE	-738.8
ROIC	-141.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-44.64%
EPS Growth Years	0
Revenue Growth Years	0x
Revenue Growth3 Y	-54.62x
Revenue Growth5 Y	-54.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$5.6M
Cash	$3.8M
Current Assets	$4.8M
Current Liabilities	$7.4M
Debt	$5.3M
Equity	$-1.8M
Interest Coverage	-134.9
Liabilities	$7.4M
Long Term Assets	$739,052
Long Term Liabilities	$0
Net Cash	$-1.5M
Net Cash By Market Cap	$-12.67
Tangible Book Value	$-1.8M
Tangible Book Value Per Share	$-0.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.65
Net Working Capital	$-1M
Quick ratio	0.51
Working Capital	$-2.6M
Working Capital Turnover	$0.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.31%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-44.62%
200-day SMA	1.01
50-day SMA	0.39
50-day SMA vs 200-day SMA	50under200
All Time High	19.51
All Time High Change	-98.29%
All Time High Date	2024-12-19
All Time Low	0.31
All Time Low Change	8.69%
All Time Low Date	2026-03-30
ATR	0.04
Beta1y	1.71
Beta2y	0.73
Ch YTD	-67.37
High	0.35
High52	3.33
High52 Date	2025-07-15
High52ch	-90.01%
Low	0.33
Low52	0.31
Low52 Date	2026-03-30
Low52ch	8.69%
Ma50ch	-15.66%
Price vs 200-day SMA	-66.89%
RSI	37.79
RSI Monthly	9.11
RSI Weekly	31.23
Sharpe ratio	0.34x
Sortino ratio	0.7
Total Return	-20.31%
Tr YTD	-67.37
Tr1m	-4.91%
Tr1w	-14.67%
Tr3m	-44.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	186,000x
Operating Income	$-8.9M
Operating margin	-40,873.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,330,326%
Float Percent	50.52%
Net Borrowing	5,433,568
Shares Insiders	49.48%
Shares Institutions	4.48%
Shares Out	36,281,252
Shares Qo Q	12.16%
Shares Yo Y	20.31%
Short Float	0.41%
Short Ratio	0.61
Short Shares	0.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	97,045.65x
Bv Per Share	-0.05
Ch1m	-4.91
Ch1w	-14.67
Ch1y	-44.62
Ch3m	-44.48
Ch6m	-74.98
Change	-3.26%
Change From Open	-4.64
Close	0.34
Days Gap	1.45
Dollar Volume	16,840.3
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-8.9M
EPS	$-0.25
F Score	1
Financing CF	5,433,568
Fiscal Year End	December
Founded	2,015
Ipr	-91.68
Iprfo	-91.68
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-01
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-01
Ma150	0.86
Ma150ch	-61.49%
Ma20	0.39
Ma20ch	-15.1%
Net CF	19,832
Next Earnings Date	2026-05-22
Open	0.35
Optionable	No
Position In Range	4.44
Post Close	0.33
Postmarket Change Percent	0.03
Postmarket Price	$0.33
Ppne	23,214
Price Date	2026-05-08
Relative Volume	0.52x
Revenue	21,796x
SBC By Revenue	11,096.15x
Share Based Comp	2,418,516
Tr6m	-74.98%
Us State	Florida
Volume	50,602
Z Score	-10.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does JUNS pay a dividend?

Capital-return profile for this ticker.

Performance

JUNS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JUNS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.5%

Float: +50.5% of shares outstanding

Insider ownership

+49.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

JUNS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.8

Neutral momentum band

Price vs 200-day MA

-66.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JUNS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current JUNS stock rating?

Jupiter Neurosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full JUNS analysis?

The full report lives at /stocks/JUNS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for JUNS?

The latest report frames JUNS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the JUNS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.